Science & ResearchAug 3, 2026
The next generation of antibody-drug conjugates.
Antibody-drug conjugates (ADCs)-composed of a monoclonal antibody linked to a payload-were designed to deliver high concentrations of cytotoxic agents to cancer cells.
Antibody-drug conjugates (ADCs)-composed of a monoclonal antibody linked to a payload-were designed to deliver high concentrations of cytotoxic agents to cancer cells. Since their inception, a deeper understanding of the mechanisms of action and resistance to ADCs in patients…
Sign in to learn & save →
The frontier is open to all. Sign in to learn this from first principles and save it to your knowledge base.